placeholder image
C. Mathieu All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • The role of ultra-rapid-acting insulin analogs in diabetes: an expert consensus. 
    Journal of Diabetes Science and Technology. 2025
  • Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin pens. 
    Diabetes Technology & Therapeutics. 2024
  • Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial. 
    Lancet (London, England). 2024
  • CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes. 
    Cardiovascular Diabetology. 2023
  • Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter]. 
    Diabetologia. 2021
  • Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies. 
    Diabetes, Obesity & Metabolism. 2021
  • Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). 
    Pediatric Diabetes. 2020
  • Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). 
    Diabetologia. 2020
  • Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (onset 1). 
    Diabetes care. 2017
  • Clinical utility of SMBG: recommendations on the use and reporting of SMBG in clinical research. 
    Diabetes care. 2015
  • A comparison between simplified and intensive dose-titration algorithms using AIR inhaled insulin for insulin-naive patients with type 2 diabetes in a randomized noninferiority trial. 
    Diabetes Technology & Therapeutics. 2009
    • Review
  • Biomarkers for the diagnosis of heart failure in people with diabetes: a consensus report from Diabetes Technology Society [review]. 
    Progress in Cardiovascular Diseases. 2023
  • Continuous glucose monitoring and metrics for clinical trials: an international consensus statement [review]. 
    The lancet. Diabetes & endocrinology. 2023
  • Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time-in-Range [review]. 
    Diabetes care. 2019
  • Role of continuous glucose monitoring in clinical trials: recommendations on reporting [review]. 
    Diabetes Technology & Therapeutics. 2017
    • Abstract
  • Double-blind mealtime faster-acting insulin aspart vs. insulin aspart in basal-bolus improves glycemic control in T1D: the Onset 1 Trial [abstract #293-OR]. 
    Diabetes. 2016
    • Contact
    full name
  • C. Mathieu
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration